Likewise, surprisingly, for pBMSCs treated with OM + BMP-2, osteogenic differentiation even tended to be improved under the inhibition of TGF-β and BMP signaling compared to those with no inhibitor used (Figure 4B, Table S3). Here, TGFB1 is linked to ocular melanoma.